Buell Jennifer
Insider CIK 1711184 · PTIX Director · AGEN VP Research & External Affairs, Director · INKT See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INKT MiNK Therapeutics, Inc. | S Sale | 2026-10-12 | 2026-10-14 | 6,938 | $10.56 | $73.3K | 74,195 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | M Exercise deriv | 2026-10-11 | 2026-10-14 | 23,191 | — | $0 | 46,382 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | M Exercise | 2026-10-11 | 2026-10-14 | 23,191 | — | — | 81,133 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2026-08-05 | 2026-08-07 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2026-08-05 | 2026-08-07 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2026-04-24 | 2026-04-28 | 300,000 | — | $0 | 300,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2026-04-24 | 2026-04-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-06 | 31,474 | $11.12 | $350.0K | 67,966 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | F Tax w/h | 2026-01-02 | 2026-01-14 | 10,024 | $11.12 | $111.5K | 57,942 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | F Tax w/h | 2025-09-09 | 2025-10-03 | 5,351 | $15.36 | $82.2K | 36,492 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2025-09-09 | 2025-09-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2025-09-09 | 2025-09-11 | 18,229 | $15.36 | $280.0K | 41,913 | SEC↗ |
| AGEN AGENUS INC | A Award | 2025-05-02 | 2025-05-06 | 581 | $3.11 | $1.8K | 19,738 | SEC↗ |
| AGEN AGENUS INC | A Award | 2025-04-18 | 2025-05-05 | 869 | $2.08 | $1.8K | 19,157 | SEC↗ |
| AGEN AGENUS INC | A Award | 2025-04-04 | 2025-04-10 | 1,159 | $1.56 | $1.8K | 18,288 | SEC↗ |
| AGEN AGENUS INC | A Award | 2025-03-21 | 2025-03-27 | 1,123 | $1.61 | $1.8K | 17,129 | SEC↗ |
| AGEN AGENUS INC | A Award | 2025-03-07 | 2025-03-24 | 409 | $2.35 | $961 | 15,646 | SEC↗ |
| AGEN AGENUS INC | A Award | 2025-02-21 | 2025-03-05 | 626 | $3.32 | $2.1K | 15,318 | SEC↗ |
| AGEN AGENUS INC | A Award | 2025-02-21 | 2025-03-11 | 545 | $3.32 | $1.8K | 15,237 | SEC↗ |
| AGEN AGENUS INC | A Award | 2025-02-07 | 2025-02-18 | 516 | $3.50 | $1.8K | 14,692 | SEC↗ |
| AGEN AGENUS INC | A Award | 2025-01-24 | 2025-01-28 | 776 | $3.57 | $2.8K | 14,446 | SEC↗ |
| AGEN AGENUS INC | F Tax w/h | 2025-01-24 | 2025-02-04 | 270 | $3.57 | $964 | 14,176 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2024-11-14 | 2024-11-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| PTIX Protagenic Therapeutics, I | A Award deriv | 2024-03-25 | 2024-03-29 | 75,000 | $1.74 | $130.5K | 75,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2024-01-16 | 2024-01-18 | 660,919 | — | $0 | 660,919 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2024-01-16 | 2024-01-18 | 500,000 | — | $0 | 500,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2023-10-11 | 2023-10-13 | 695,750 | — | $0 | 0 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | J Other | 2023-10-11 | 2023-10-13 | 695,750 | — | $0 | 232,165 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | F Tax w/h | 2023-10-03 | 2023-10-03 | 65,000 | $0.94 | $61.1K | 927,915 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | F Tax w/h | 2023-10-02 | 2023-10-03 | 58,550 | $1.04 | $60.9K | 992,915 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | F Tax w/h | 2023-09-29 | 2023-10-03 | 25,000 | $1.15 | $28.7K | 1,051,465 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | M Exercise deriv | 2023-09-27 | 2023-09-29 | 695,750 | — | $0 | 695,750 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | M Exercise | 2023-09-27 | 2023-09-29 | 695,750 | — | $0 | 1,076,465 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2023-01-09 | 2023-01-11 | 500,000 | — | $0 | 500,000 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award | 2023-01-09 | 2023-01-11 | 171,990 | $2.32 | $399.0K | 380,715 | SEC↗ |
| INKT MiNK Therapeutics, Inc. | A Award deriv | 2022-01-21 | 2022-01-25 | 679,800 | — | $0 | 679,800 | SEC↗ |
| AGEN AGENUS INC | A Award | 2021-06-30 | 2021-07-02 | 10,597 | $5.49 | $58.2K | 127,091 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2021-06-15 | 2021-07-02 | 900,000 | — | $0 | 900,000 | SEC↗ |
| AGEN AGENUS INC | A Award | 2021-04-02 | 2021-04-05 | 80,838 | $2.87 | $232.0K | 116,494 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2020-12-17 | 2020-12-21 | 900,000 | — | $0 | 900,000 | SEC↗ |
| PTIX Protagenic Therapeutics, I | A Award deriv | 2020-07-18 | 2020-07-21 | 145,000 | $1.75 | $253.8K | 145,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2020-06-15 | 2020-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2019-12-24 | 2019-12-27 | 500,000 | — | $0 | 500,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2019-07-23 | 2019-07-25 | 84,000 | — | $0 | 84,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2019-06-19 | 2019-06-21 | 300,000 | — | $0 | 300,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2018-11-07 | 2018-11-14 | 130,000 | — | $0 | 130,000 | SEC↗ |
| AGEN AGENUS INC | A Award deriv | 2018-06-20 | 2018-06-22 | 150,000 | $5.65 | $847.5K | 150,000 | SEC↗ |
| AGEN AGENUS INC | S Sale | 2017-12-12 | 2017-12-14 | 3,511 | $3.46 | $12.1K | 35,656 | SEC↗ |
| AGEN AGENUS INC | A Award | 2017-10-09 | 2017-12-14 | 10,431 | $3.59 | $37.4K | 39,167 | SEC↗ |
| AGEN AGENUS INC | A Award | 2017-09-03 | 2017-09-06 | 4,375 | $3.72 | $16.3K | 28,736 | SEC↗ |